Clene (CLNN) director granted 4,291-share stock option package

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Clene Inc. director Shalom Jacobovitz received two stock option awards as equity compensation. One option covers 2,791 shares of common stock at an exercise price of $6.81 per share and vests immediately. The second option covers 1,500 shares at the same exercise price and vests in 12 equal monthly installments starting on June 21, 2026.

These awards are structured as derivative securities that can be exercised into common stock before their expiration on May 20, 2036, and reflect routine compensation rather than open-market buying or selling.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Jacobovitz Shalom

Role null

Type	Security	Shares	Price	Value
Grant/Award	stock option	1,500	$0.00	--
Grant/Award	stock option	2,791	$0.00	--

Holdings After Transaction: stock option — 1,500 shares (Direct, null)

Footnotes (1)

This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested. This option was granted on May 21, 2026 as an option for 2,791 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

Key Figures

Option grant (immediate vesting): 2,791 shares at $6.81/share Option grant (monthly vesting): 1,500 shares at $6.81/share Total underlying shares: 4,291 shares +2 more

5 metrics

Option grant (immediate vesting) 2,791 shares at $6.81/share Stock option covering 2,791 common shares, vests immediately

Option grant (monthly vesting) 1,500 shares at $6.81/share Stock option covering 1,500 common shares, vests over 12 months

Total underlying shares 4,291 shares Combined underlying common stock from both option awards

Option expiration date May 20, 2036 Expiration for both stock option awards

Monthly vesting start June 21, 2026 Start of 12 monthly vesting installments for 1,500-share grant

Key Terms

stock option, exercise price, vests immediately upon grant, equal monthly installments

4 terms

stock option financial

"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"at an exercise price of $6.81 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests immediately upon grant financial

"The options vest immediately upon grant."

equal monthly installments financial

"The options vest in 12 equal monthly installments on the 21st day of each calendar month"

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 01:57 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacobovitz Shalom

(Last)

(First)

(Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY

UTAH

84121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
stock option	$6.81	05/21/2026		A		1,500		⁽¹⁾	05/20/2036	common stock	1,500	$0	1,500	D
stock option	$6.81	05/21/2026		A		2,791		⁽²⁾	05/20/2036	common stock	2,791	$0	2,791	D

Explanation of Responses:

1. This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

2. This option was granted on May 21, 2026 as an option for 2,791 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Clene (CLNN) disclose for Shalom Jacobovitz?

Clene reported that director Shalom Jacobovitz received two stock option awards. One covers 2,791 shares vesting immediately, and another covers 1,500 shares vesting monthly. Both options are exercisable at an exercise price of $6.81 per share as equity compensation.

How many Clene (CLNN) shares are covered by the new options?

The new stock options cover a total of 4,291 underlying shares of Clene common stock. One grant is for 2,791 shares that vest immediately, and another is for 1,500 shares that vest over time in 12 equal monthly installments.

What is the exercise price of the new Clene (CLNN) stock options?

Both option grants to director Shalom Jacobovitz have an exercise price of $6.81 per share. This is the fixed price at which he can purchase Clene common stock under these options if he chooses to exercise them in the future.

How do the vesting terms differ for the Clene (CLNN) option grants?

One option for 2,791 shares vests immediately on the grant date, making all shares exercisable at once. The other option for 1,500 shares vests in 12 equal monthly installments beginning June 21, 2026, gradually becoming exercisable over one year.

Are the Clene (CLNN) insider transactions market purchases or sales?

The reported transactions are grants of stock options as compensation, not open-market purchases or sales. They are coded as awards, giving the director rights to buy shares later at $6.81 per share rather than reflecting immediate trading activity.

When do the new Clene (CLNN) stock options expire?

Both stock option awards to Shalom Jacobovitz expire on May 20, 2036. This means he can choose to exercise vested options any time before that date, subject to plan and agreement terms, to acquire Clene common shares at the exercise price.